This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease

Inclusion Criteria:

• Adult (>18y)
• Owing a social security insurance
• Any solid cancer diagnosed by histopathology or cytology
• Patient with blood sampling required as per standard of care
• Informed consent signed

Exclusion Criteria:

• Refusal to participate
• No blood sampling required as per standard of care
• Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
• Heterologous blood transfusion in the last 48 hours
• Weight under 20 kg

Adult with solid cancer

A decision on sharing individual participant data has not yet been made. Data sharing will depend on sponsor policy, ethical approval, and compliance with applicable regulations.